ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 528 filers reported holding ASTRAZENECA PLC in Q2 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,906,000 | +171.9% | 34,774 | +162.4% | 0.06% | +146.2% |
| Q2 2020 | $701,000 | +44.8% | 13,253 | +22.2% | 0.03% | +23.8% |
| Q1 2020 | $484,000 | -22.8% | 10,844 | -14.0% | 0.02% | 0.0% |
| Q4 2019 | $627,000 | +8.9% | 12,608 | -3.0% | 0.02% | +5.0% |
| Q3 2019 | $576,000 | +37.5% | 12,996 | +28.1% | 0.02% | +42.9% |
| Q2 2019 | $419,000 | +7.7% | 10,143 | +3.9% | 0.01% | +7.7% |
| Q1 2019 | $389,000 | -38.5% | 9,758 | -41.6% | 0.01% | -48.0% |
| Q4 2018 | $633,000 | -14.3% | 16,719 | -9.7% | 0.02% | 0.0% |
| Q3 2018 | $739,000 | +3.5% | 18,507 | -8.4% | 0.02% | -7.4% |
| Q2 2018 | $714,000 | -5.1% | 20,214 | -6.2% | 0.03% | -6.9% |
| Q1 2018 | $752,000 | -8.8% | 21,559 | -9.6% | 0.03% | -12.1% |
| Q4 2017 | $825,000 | +10.0% | 23,845 | +7.6% | 0.03% | +3.1% |
| Q3 2017 | $750,000 | +13.1% | 22,151 | +14.0% | 0.03% | +6.7% |
| Q2 2017 | $663,000 | -0.5% | 19,425 | -4.7% | 0.03% | -11.8% |
| Q1 2017 | $666,000 | +49.3% | 20,385 | +24.8% | 0.03% | +47.8% |
| Q4 2016 | $446,000 | -25.9% | 16,329 | -10.8% | 0.02% | -28.1% |
| Q3 2016 | $602,000 | +75.5% | 18,316 | +59.1% | 0.03% | +68.4% |
| Q2 2016 | $343,000 | -13.6% | 11,509 | -18.2% | 0.02% | -13.6% |
| Q1 2016 | $397,000 | -18.6% | 14,076 | -3.0% | 0.02% | -12.0% |
| Q4 2015 | $488,000 | +10.2% | 14,505 | +4.5% | 0.02% | +4.2% |
| Q3 2015 | $443,000 | +3.0% | 13,882 | +105.8% | 0.02% | +26.3% |
| Q2 2015 | $430,000 | +47.3% | 6,746 | +57.5% | 0.02% | 0.0% |
| Q1 2015 | $292,000 | -25.5% | 4,283 | -23.4% | 0.02% | -34.5% |
| Q4 2014 | $392,000 | +14.6% | 5,592 | +16.7% | 0.03% | +7.4% |
| Q3 2014 | $342,000 | -7.3% | 4,792 | -16.5% | 0.03% | -3.6% |
| Q1 2014 | $369,000 | -85.9% | 5,737 | -86.9% | 0.03% | -86.7% |
| Q4 2013 | $2,618,000 | -46.5% | 43,760 | -53.2% | 0.21% | -26.3% |
| Q3 2013 | $4,891,000 | +69.1% | 93,428 | +53.0% | 0.28% | +23.4% |
| Q2 2013 | $2,893,000 | – | 61,046 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |